OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 82 filers reported holding OVID THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,838,630 | +16.6% | 478,810 | -0.4% | 0.00% | – |
| Q2 2023 | $1,577,034 | +462.6% | 480,803 | +342.5% | 0.00% | – |
| Q1 2023 | $280,322 | +54.9% | 108,652 | +11.6% | 0.00% | – |
| Q4 2022 | $181,023 | +1.1% | 97,324 | -0.0% | 0.00% | – |
| Q3 2022 | $179,000 | 0.0% | 97,334 | +17.0% | 0.00% | – |
| Q2 2022 | $179,000 | -31.9% | 83,213 | -0.6% | 0.00% | – |
| Q1 2022 | $263,000 | -6.1% | 83,681 | -4.1% | 0.00% | – |
| Q4 2021 | $280,000 | -4.4% | 87,227 | 0.0% | 0.00% | – |
| Q3 2021 | $293,000 | -8.7% | 87,227 | +6.3% | 0.00% | – |
| Q2 2021 | $321,000 | -83.4% | 82,052 | -83.0% | 0.00% | – |
| Q1 2021 | $1,938,000 | +67.4% | 481,863 | -3.9% | 0.00% | – |
| Q4 2020 | $1,158,000 | -58.3% | 501,249 | +3.5% | 0.00% | -100.0% |
| Q3 2020 | $2,780,000 | -25.4% | 484,259 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $3,725,000 | +1682.3% | 505,487 | +623.7% | 0.00% | – |
| Q1 2020 | $209,000 | -0.9% | 69,849 | +37.4% | 0.00% | – |
| Q4 2019 | $211,000 | +11.1% | 50,821 | -13.4% | 0.00% | – |
| Q3 2019 | $190,000 | -43.1% | 58,716 | -67.5% | 0.00% | – |
| Q2 2019 | $334,000 | -0.6% | 180,491 | -4.7% | 0.00% | – |
| Q1 2019 | $336,000 | 0.0% | 189,352 | +36.4% | 0.00% | – |
| Q4 2018 | $336,000 | -58.2% | 138,871 | -2.0% | 0.00% | – |
| Q3 2018 | $804,000 | -20.4% | 141,733 | +9.4% | 0.00% | – |
| Q2 2018 | $1,010,000 | +20.7% | 129,497 | +9.3% | 0.00% | – |
| Q1 2018 | $837,000 | +30.2% | 118,430 | +81.7% | 0.00% | – |
| Q4 2017 | $643,000 | +30.4% | 65,166 | +13.2% | 0.00% | – |
| Q3 2017 | $493,000 | -18.4% | 57,547 | 0.0% | 0.00% | – |
| Q2 2017 | $604,000 | – | 57,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |